We are live on ! Find out more
MWNA

Marshall Wace North America Portfolio holdings

AUM $23.5B
1-Year Est. Return 46.46%
This Fund
S&P 500
This Quarter Est. Return
+10.61%
1 Year Est. Return
+46.46%
3 Year Est. Return
+109.4%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$20.7B
AUM Growth
+$3.14B
Cap. Flow
+$1.47B
Cap. Flow %
7.1%
Top 10 Hldgs %
15.76%
Holding
1,778
New
496
Increased
377
Reduced
371
Closed
524

Top Buys

Rank Stock Value
1
HCA icon
HCA Healthcare
HCA
+$221M
2
GDDY icon
GoDaddy
GDDY
+$159M
3
CI icon
Cigna
CI
+$135M
4
PFE icon
Pfizer
PFE
+$132M
5
HOLX
Hologic
HOLX
+$98.3M

Top Sells

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$156M
2
AAPL icon
Apple
AAPL
+$148M
3
MSFT icon
Microsoft
MSFT
+$126M
4
MCD icon
McDonald's
MCD
+$121M
5
DHR icon
Danaher
DHR
+$107M

Sector Composition

Rank Sector Weight
1 Healthcare 25.95%
2 Technology 21.4%
3 Consumer Discretionary 12.43%
4 Industrials 11.77%
5 Financials 6.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TAC icon
476
TransAlta
TAC
$3.93B
$3.14M 0.02%
438,283
+371,110
+552% +$2.41M
VRSN icon
477
VeriSign
VRSN
$26.6B
$3.13M 0.02%
16,225
-5,387
-25% -$1.01M
TME icon
478
Tencent Music
TME
$15.6B
$3.08M 0.01%
262,645
+230,382
+714% +$2.96M
CLGX
479
DELISTED
Corelogic, Inc.
CLGX
$3.07M 0.01%
+70,170
New +$2.98M
AEP icon
480
American Electric Power
AEP
$68.4B
$3.06M 0.01%
+32,435
New +$3M
PE
481
DELISTED
PARSLEY ENERGY INC
PE
$3.06M 0.01%
162,046
-29,316
-15% -$484K
PRAH
482
DELISTED
PRA Health Sciences, Inc.
PRAH
$3.06M 0.01%
27,559
+20,666
+300% +$2.13M
EDU icon
483
New Oriental
EDU
$8.98B
$3.02M 0.01%
24,918
+20,978
+532% +$2.51M
INXN
484
DELISTED
Interxion Holding N.V.
INXN
$3.02M 0.01%
+36,054
New +$3.01M
ADC icon
485
Agree Realty
ADC
$9.41B
$3.02M 0.01%
+42,940
New +$3.17M
HOV icon
486
Hovnanian Enterprises
HOV
$807M
$3.01M 0.01%
144,405
+97,913
+211% +$2.31M
PRLB icon
487
Protolabs
PRLB
$2.13B
$3.01M 0.01%
+29,659
New +$2.94M
UDR icon
488
UDR
UDR
$12.3B
$3.01M 0.01%
+64,438
New +$3.09M
REAL icon
489
The RealReal
REAL
$1.5B
$3M 0.01%
+159,232
New +$3.05M
RYAAY icon
490
Ryanair
RYAAY
$31.3B
$2.99M 0.01%
85,445
+58,257
+214% +$1.87M
O icon
491
Realty Income
O
$59.1B
$2.92M 0.01%
+41,004
New +$3.05M
BMY icon
492
Bristol-Myers Squibb
BMY
$132B
$2.92M 0.01%
45,494
-86,932
-66% -$4.98M
PEG icon
493
Public Service Enterprise Group
PEG
$37.7B
$2.91M 0.01%
+49,358
New +$2.99M
MOMO
494
Hello Group
MOMO
$866M
$2.9M 0.01%
86,645
+79,411
+1,098% +$2.82M
VYX icon
495
NCR Voyix
VYX
$1.14B
$2.89M 0.01%
133,826
+135
+0.1% +$2.63K
RNR icon
496
RenaissanceRe
RNR
$13.4B
$2.88M 0.01%
+14,689
New +$2.78M
COR icon
497
Cencora
COR
$61.2B
$2.85M 0.01%
33,494
+20,573
+159% +$1.76M
GCO icon
498
Genesco
GCO
$422M
$2.83M 0.01%
59,155
+12,559
+27% +$521K
TNL icon
499
Travel + Leisure Co
TNL
$4.7B
$2.81M 0.01%
+54,341
New +$2.6M
RDN icon
500
Radian Group
RDN
$4.93B
$2.8M 0.01%
+111,306
New +$2.77M
18 19
20
21 22

Similar funds

TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
PAM
PFM Asset Management Harrisburg, Pennsylvania $5.36B AUM 21.04% 1-Year Est. Return
HB
Homrich & Berg Atlanta, Georgia $4.47B AUM 22.61% 1-Year Est. Return
MWA
Marshall Wace Asia Central, Hong Kong $4.23B AUM 69.9% 1-Year Est. Return
3SCA
36 South Capital Advisors London, United Kingdom $3.76B AUM
HFCIV
H&F Corporate Investors VII San Francisco, California $3.61B AUM 26.49% 1-Year Est. Return
DVC
Deer VIII & Co Larchmont, New York $3.56B AUM
NAM
NorthCoast Asset Management Greenwich, Connecticut $2.74B AUM 25.44% 1-Year Est. Return

Marshall Wace North America's Q4 2019 Portfolio in Review

As of Q4 2019, Marshall Wace North America held 1,778 positions worth $20.7B, up 18% from $17.6B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Marshall Wace North America deployed $1.47B of net new capital in Q4 2019, opening 496 new positions and adding to 377 existing holdings. Its largest new stake was Deere & Co: 519,053 shares worth $89.9M.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 26% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Gilead Sciences, an estimated $156M trimmed.

  • Marshall Wace North America's largest Q4 2019 buy was Deere & Co: 519,053 shares worth $89.9M.
  • Marshall Wace North America added most to HCA Healthcare in Q4 2019, an estimated $221M increase.
  • Marshall Wace North America's biggest Q4 2019 reduction was Gilead Sciences, cutting an estimated $156M.
  • Marshall Wace North America fully exited McDonald's in Q4 2019, selling an estimated $121M.
  • Marshall Wace North America's ten largest holdings make up 16% of its $20.7B portfolio in Q4 2019.
  • Marshall Wace North America opened 496 new positions and closed 524 in Q4 2019.
  • Marshall Wace North America's portfolio value rose 18% quarter-over-quarter to $20.7B.

Based on Marshall Wace North America's 13F filing for Q4 2019, filed 14 Feb 2020.